Zantac settlements

Ranitidine, a heartburn medicine sold under the brand name Zantac among others, was pulled from shelves in 2019, following disclosure of potential carcinogenic effects, which its manufacturers were accused of "engaging in a decades-long scheme to conceal."

This keyword could refer to multiple things. Here are some suggestions: